Details for New Drug Application (NDA): 202122
✉ Email this page to a colleague
The generic ingredient in ENTECAVIR is entecavir. There are eighteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the entecavir profile page.
Summary for 202122
Tradename: | ENTECAVIR |
Applicant: | Teva Pharms Usa |
Ingredient: | entecavir |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
Approval Date: | Aug 26, 2014 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
Approval Date: | Aug 26, 2014 | TE: | RLD: | No |
Complete Access Available with Subscription